GOAL Outlook for 2021: Rotation inoculation — remain pro-risk
We are pro-risk for 2021 and expect the pro-cyclical rotation across and within assets to continue, supported by a strong economic recovery from the COVID-19 shock. With a favourable growth/inflation mix and still elevated equity risk premia we are OW equities and UW bonds.
20 Nov 2020 | 5:46pm GMT | Research | Portfolio Strategy - Christian Mueller-Glissmann and others
Also read: US Weekly Kickstart: Investor response to our 2021 US Equity Outlook (20 Nov 2020)
Webcast Replay: GOAL Outlook 2021 - Rotation Inoculation
with Christian Mueller-Glissman, Peter Oppenheimer, Kamakshya Trivedi, Praveen Korapaty, Damien Courvalin and Amanda Lynam.
Canada: From Virus to Vaccine
Our 2021 full-year GDP growth estimate of 4.8% is modestly above consensus expectations but really a tale of two halves. We are somewhat negative on the winter with a slowdown in growth to +3% in Q4 and 0% in Q1 as we expect further virus spread with temperatures set to drop lower.
20 Nov 2020 | 6:35PM EST | Research | Economics - Daan Struyven and others
with Jeff Currie, Damien Courvalin, Samantha Dart, Nicholas Snowdon, Mikhail Sprogis and Chris Hussey.
with Lotfi Karoui, Amanda Lynam, Frank Jarman and Chris Hussey.